Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 22.65
+0.95 (4.38%)
Oct 8, 2026, 1:30 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.37 billion as of October 9, 2026. It is the 31,504th most valuable company in the world and the 1,879th biggest in Taiwan. Its market cap has decreased by 12.88% in one year.
Market Cap
1.37B
Enterprise Value
983.60M
Revenue
345.45M
Global Rank
Country Rank
#1,879 Taiwan
PE Ratio
30.61
ChartMarket Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.37B, a decrease of -52.86%. That is a compound annual growth rate of -4.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.37B | -0.22% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 1.64B |
| Greenyn Biotechnology | 1.57B |
| Andros Pharmaceuticals Co.,Ltd | 1.54B |
| Great Novel Therapeutics Biotech & Medicals | 1.49B |
| Sunny Pharmtech | 1.49B |
| Advagene Biopharma | 1.48B |
| GenMont Biotech Incorporation | 1.46B |
| NeoCore Technology | 1.24B |